Forma Therapeutics Holdings Inc

NASDAQ:FMTX  
6.00
+0.15 (+2.56%)
Earnings Announcements

Forma Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/06/2022 11:33 GMT
Forma Therapeutics Holdings Inc (FMTX) - Forma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Cash, Cash Equivalents and Marketable Securities Were $441.3 Million As of March 31, 2022.
Current Cash Runway is Projected Through Q3 of 2024.
Qtrly Loss per Share $0.93.
Q1 Earnings per Share View $-1.05 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.00

More details on our Analysts Page.